Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

Recruiting

Phase 1

GS-0201Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

Sponsor:

Gilead Sciences

Code:

NCT06167317

Conditions

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GS-0201

Sacituzumab Govitecan

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by Gilead Sciences on 2026-05-28.